2406, 2021
BioLoomics & KIF1A.ORG search for Treatments and a Cure for KAND
BioLoomics is joining KIF1A.ORG in its search for a treatment and cure for KIF1A-Associated Neurological Disorder (KAND). We are applying our evolution-in-a-microscope technology to build high throughput ...
1505, 2021
Dr. Michael Stowell Joins Scientific Advisory Board
BioLoomics is forming a Scientific Advisory Board (SAB) to bring together diverse experts to bolster our mission to produce drug discovery assays and the first biosensing biologics with ...
1105, 2021
BioLoomics Closed $575,000 Seed Funding Round
BioLoomics closed a $575,000 round of seed funding on May 11, 2021. The funds were contributed by private investors, including several investors who participated in the pre-seed round. ...